Drugs Made In America Acquisition II Corp. (DMII)
NasdaqGM · USD · Financial Services · Shell Companies
$10.20 (+0.05%) as of
Key statistics
- Market cap
- 649.42M
- P/E (TTM)
- 33.98
- EPS (TTM)
- 0.30
- Dividend yield
- 0.00%
- 52-week range
- 9.86 – 10.33
- Profit margin
- 0.00%
- Volume
- 187.66k
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Headquarters
- New York, NY, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.